Health costs in anthroposophic therapy users: a two-year prospective cohort study
2006

Health Costs in Anthroposophic Therapy Users

Sample size: 717 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hamre Harald J, Witt Claudia M, Glockmann Anja, Ziegler Renatus, Willich Stefan N, Kiene Helmut

Primary Institution: Institute for Applied Epistemology and Medical Methodology

Hypothesis

Do anthroposophic therapies lead to reduced health costs for chronic disease patients?

Conclusion

Patients starting anthroposophic therapies for chronic disease did not see an increase in health costs in the first year and experienced a reduction in the second year, primarily due to decreased hospitalizations.

Supporting Evidence

  • Total health costs in the first study year did not differ significantly from the pre-study year.
  • In the second year, costs were significantly reduced by 416 Euro compared to the pre-study year.
  • Hospitalization and sick leave accounted for more than half of total health costs in each period.

Takeaway

This study looked at how much money people spent on health care when they used anthroposophic therapies. It found that costs didn't go up in the first year and actually went down in the second year.

Methodology

A prospective cohort study analyzing health costs in 717 outpatients starting anthroposophic therapies over two years.

Potential Biases

Potential recall bias in patient self-reporting could affect cost data accuracy.

Limitations

The study lacked a comparison group and relied on patient self-reporting for resource utilization.

Participant Demographics

Median age was 39 years; 73% were female; 78.8% had at least one comorbid disease.

Statistical Information

P-Value

0.035

Confidence Interval

95%-CI 264 Euro to 960 Euro

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6963-6-65

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication